These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 15509617)
1. Alternative dosing regimens of liposomal amphotericin B (AmBisome) effective in treating murine systemic candidiasis. Adler-Moore JP; Olson JA; Proffitt RT J Antimicrob Chemother; 2004 Dec; 54(6):1096-102. PubMed ID: 15509617 [TBL] [Abstract][Full Text] [Related]
2. Effects of dosing regimen on accumulation, retention and prophylactic efficacy of liposomal amphotericin B. Smith PJ; Olson JA; Constable D; Schwartz J; Proffitt RT; Adler-Moore JP J Antimicrob Chemother; 2007 May; 59(5):941-51. PubMed ID: 17400589 [TBL] [Abstract][Full Text] [Related]
3. Treatment of Candida glabrata infection in immunosuppressed mice by using a combination of liposomal amphotericin B with caspofungin or micafungin. Olson JA; Adler-Moore JP; Smith PJ; Proffitt RT Antimicrob Agents Chemother; 2005 Dec; 49(12):4895-902. PubMed ID: 16304150 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of alternative dosing regimens of poly-aggregated amphotericin B. Espada R; Valdespina S; Molero G; Dea MA; Ballesteros MP; Torrado JJ Int J Antimicrob Agents; 2008 Jul; 32(1):55-61. PubMed ID: 18534826 [TBL] [Abstract][Full Text] [Related]
5. Single-dose AmBisome (Liposomal amphotericin B) as prophylaxis for murine systemic candidiasis and histoplasmosis. Garcia A; Adler-Moore JP; Proffitt RT Antimicrob Agents Chemother; 2000 Sep; 44(9):2327-32. PubMed ID: 10952575 [TBL] [Abstract][Full Text] [Related]
6. Activity of aminocandin (IP960) compared with amphotericin B and fluconazole in a neutropenic murine model of disseminated infection caused by a fluconazole-resistant strain of Candida tropicalis. Warn PA; Sharp A; Morrissey G; Denning DW J Antimicrob Chemother; 2005 Sep; 56(3):590-3. PubMed ID: 16046462 [TBL] [Abstract][Full Text] [Related]
7. A novel murine model of cerebral scedosporiosis: lack of efficacy of amphotericin B. Capilla J; Mayayo E; Serena C; Pastor FJ; Guarro J J Antimicrob Chemother; 2004 Dec; 54(6):1092-5. PubMed ID: 15509616 [TBL] [Abstract][Full Text] [Related]
8. Therapeutic and prophylactic efficacy of aminocandin (IP960) against disseminated candidiasis in mice. Najvar LK; Bocanegra R; Wiederhold NP; Lambros C; Najarian N; Patterson TF; Graybill JR Clin Microbiol Infect; 2008 Jun; 14(6):595-600. PubMed ID: 18397335 [TBL] [Abstract][Full Text] [Related]
9. Comparative study on the efficacy of AmBisome and Fungizone in a mouse model of pulmonary aspergillosis. Takemoto K; Yamamoto Y; Ueda Y; Sumita Y; Yoshida K; Niki Y J Antimicrob Chemother; 2006 Apr; 57(4):724-31. PubMed ID: 16446374 [TBL] [Abstract][Full Text] [Related]
10. Effects of amphotericin B incorporated into liposomes and in lipid suspensions in the treatment of murine candidiasis. Kretschmar M; Nichterlein T; Hannak D; Hof H Arzneimittelforschung; 1996 Jul; 46(7):711-5. PubMed ID: 8842344 [TBL] [Abstract][Full Text] [Related]
11. Combined antifungal therapy in a murine infection by Candida glabrata. Mariné M; Serena C; Pastor FJ; Guarro J J Antimicrob Chemother; 2006 Dec; 58(6):1295-8. PubMed ID: 17012301 [TBL] [Abstract][Full Text] [Related]
12. Toxicity, stability and pharmacokinetics of amphotericin B in immunomodulator tuftsin-bearing liposomes in a murine model. Khan MA; Owais M J Antimicrob Chemother; 2006 Jul; 58(1):125-32. PubMed ID: 16709592 [TBL] [Abstract][Full Text] [Related]
13. Therapeutic efficacy of voriconazole against a fluconazole-resistant Candida albicans isolate in a vaginal model. González GM; Portillo OJ; Uscanga GI; Andrade SE; Robledo M; Rodríguez C; Elizondo M J Antimicrob Chemother; 2009 Sep; 64(3):571-3. PubMed ID: 19570754 [TBL] [Abstract][Full Text] [Related]
14. Tolerance to amphotericin B in clinical isolates of Candida tropicalis. Barchiesi F; Maracci M; Baldassarri I; Spreghini E; Giannini D; Scalise G Diagn Microbiol Infect Dis; 2004 Nov; 50(3):179-85. PubMed ID: 15541603 [TBL] [Abstract][Full Text] [Related]
15. Low-dose amphotericin for prevention of serious fungal infection following liver transplantation. Shah T; Lai WK; Gow P; Leeming J; Mutimer D Transpl Infect Dis; 2005; 7(3-4):126-32. PubMed ID: 16390401 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of combination immunotherapy of IgM MAb B6.1 and amphotericin B against disseminated candidiasis. Han Y Int Immunopharmacol; 2010 Dec; 10(12):1526-31. PubMed ID: 20840836 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of a new formulation of amphotericin B in a murine model of disseminated infection by Candida glabrata. Mariné M; Espada R; Torrado J; Pastor FJ; Guarro J J Antimicrob Chemother; 2008 Apr; 61(4):880-3. PubMed ID: 18256113 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of high loading doses of liposomal amphotericin B in the treatment of experimental invasive pulmonary aspergillosis. Gavaldà J; Martín T; López P; Gomis X; Ramírez JL; Rodríguez D; Len O; Puigfel Y; Ruiz I; Pahissa A Clin Microbiol Infect; 2005 Dec; 11(12):999-1004. PubMed ID: 16307554 [TBL] [Abstract][Full Text] [Related]
19. Efficient treatment of murine systemic infection with Candida albicans using amphotericin B incorporated in nanosize range particles (emulsomes). Kretschmar M; Amselem S; Zawoznik E; Mosbach K; Dietz A; Hof H; Nichterlein T Mycoses; 2001; 44(7-8):281-6. PubMed ID: 11714063 [TBL] [Abstract][Full Text] [Related]
20. Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous system. Groll AH; Giri N; Petraitis V; Petraitiene R; Candelario M; Bacher JS; Piscitelli SC; Walsh TJ J Infect Dis; 2000 Jul; 182(1):274-82. PubMed ID: 10882607 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]